Seelos Therapeutics Inc (NASDAQ: SEEL) announced topline data from Part 2 of its Phase 2 study of SLS-002 (intranasal racemic ketamine) for Acute Suicidal Ideation and Behavior (ASIB) in adults with
https://jcapitalresearch.substack.com/p/vericel-corp-vcelThis report forms part of our biweekly series on short ideas. These may be cyclical or structural decline stories, stock promotes, or sometimes good companies with
International medical cannabis company Akanda Corp. (NASDAQ: AKAN) (WKN: A3DG83) and 1107385 B.C. LTD has entered a purchase deal for farming land and related operations and licenses.